Air Filtration for Heart Disease
(SAPIA Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether using a HEPA air filter (High-Efficiency Particulate Air filter) at home can slow the progression of heart disease in individuals with a history of ischemic heart disease. The study will compare two groups: one using real HEPA filters and another using a placebo filter to determine any differences. Individuals with stable ischemic heart disease living in Los Angeles County may qualify for this trial. As an unphased study, this trial offers a unique opportunity to contribute to research that could enhance heart health for many.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What prior data suggests that HEPA filtration is safe for adults with ischemic heart disease?
Research shows that HEPA air filters are generally safe for home use. Studies have found that these filters effectively reduce indoor air pollution, particularly tiny particles known as PM2.5, which can harm heart health. One study discovered that using HEPA filters at home led to a noticeable decrease in systolic blood pressure (the top number in a blood pressure reading) for people with high blood pressure. This suggests that HEPA filters not only improve air quality but may also benefit heart health.
These studies have not reported significant negative effects from using HEPA filters, indicating that users generally do not experience serious side effects. Based on this information, HEPA filters appear to be a safe choice for those considering participation in a clinical trial focused on heart health and air quality.12345Why are researchers excited about this trial?
Researchers are excited about using HEPA filtration for heart disease because it offers a non-invasive way to potentially improve heart health. Unlike medications or surgical procedures, HEPA filters work by removing tiny particulate matter (PM2.5) from indoor air, which may reduce inflammation and stress on the heart. This approach targets environmental factors contributing to heart disease, offering a unique angle compared to traditional treatments like medications or lifestyle changes. If successful, this could lead to a simple yet effective method to support cardiovascular health by improving the air quality in people's homes.
What evidence suggests that HEPA filtration is effective for heart disease?
Research has shown that HEPA filters can benefit heart health by lowering blood pressure. Studies have found that using HEPA filters significantly reduces systolic blood pressure, the top number in a blood pressure reading. For example, one study noted a 2.8 mm Hg drop in systolic blood pressure with HEPA filters, while a sham filter caused a slight increase. In this trial, participants will experience both HEPA and sham filtration to assess their effects on heart health. This suggests that HEPA filters might help lower heart disease risks. Another study pointed out that these filters can reduce exposure to harmful particles, especially in homes near highways, further supporting their heart health benefits.678910
Who Is on the Research Team?
Zhanghua Chen, PhD
Principal Investigator
University of Southern California
Junfeng Zhang, PhD
Principal Investigator
Duke University
Are You a Good Fit for This Trial?
Adults aged 65-84 living in Los Angeles County with a history of ischemic heart disease, clinically stable for the past 6 months, and weighing at least 110 pounds can join. Smokers or those with certain health conditions like active cancer treatments or degenerative diseases are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
HEPA Filtration Intervention
Participants receive true HEPA filtration to reduce indoor PM2.5 levels
Wash-out Period
Participants undergo a wash-out period between interventions
Sham Filtration Intervention
Participants receive sham filtration with HEPA filter removed
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- HEPA filtration
- Sham filtration
Trial Overview
The trial is testing if using HEPA air filters in homes can slow down the worsening of atherothrombosis (blood clotting in hardened arteries) compared to sham (fake) filters by reducing fine particle pollution indoors.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
This group of participants will be assigned to the intervention of sham filtration with HEPA filter removed at their residence for 9 months first. After 3-month wash-out period, participants will be assigned to the HEPA filtration for 9 months.
This group of participants will be assigned to the intervention of HEPA filtration with the capacity to reduce indoor PM2.5 levels at their residence for 9 months first. After 3-month wash-out period, participants will be assigned to sham filters (air purifier has the same appearance but HEPA filter is removed) for 9 months.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Southern California
Lead Sponsor
Duke University
Collaborator
National Institute of Environmental Health Sciences (NIEHS)
Collaborator
Published Research Related to This Trial
Citations
Effect of HEPA Filtration Air Purifiers on Blood Pressure
A greater percentage of larger reductions in brachial systolic blood pressure was observed among participants who had elevated SBP at the start ...
A randomized crossover trial of HEPA air filtration to reduce ...
This study has the potential to shed light on the value of using portable air filtration in homes close to highways to reduce exposure to TRAP and whether doing ...
3.
news-medical.net
news-medical.net/news/20250813/HEPA-filtration-reduces-blood-pressure-for-highway-residents.aspxHEPA filtration reduces blood pressure for highway residents
New research reveals that a simple home air purifier could be a powerful tool for cutting high blood pressure and protecting heart health ...
4.
endocrinologyadvisor.com
endocrinologyadvisor.com/news/use-of-hepa-filters-tied-to-reduced-systolic-bp/Use of HEPA Filters Tied to Reduced Systolic BP
A significant 2.8-mm Hg mean decrease in SBP was seen after HEPA filtration compared with a 0.2-mm Hg increase after sham filtration among ...
Home Air Filtration for Traffic-Related Air Pollution
Specific Aim 1: To test the effect of HEPA filtration on markers of cardiovascular risk for adults who live near urban highways. 207 participants will be ...
Effect of HEPA Filtration Air Purifiers on Blood Pressure
Conclusions: The use of in-home HEPA air purifiers resulted in clinically important reductions in SBP for people with elevated SBP in ...
Air Purifiers May Reduce Heart Risks for People Exposed ...
Researchers found that participants with elevated SBP (>120 mmHg) experienced an average 2.8 mmHg reduction in SBP after one month of HEPA ...
and Household-Level Interventions to Reduce Air Pollution ...
There is now substantial evidence that HEPA filter air purifiers reduce indoor PM2.5 concentrations and improve subclinical health indicators.
Different cardiorespiratory effects of indoor air pollution ...
The mechanic filters, such as high-efficiency particulate air (HEPA) filtration purifiers, could lower indoor pollution and have cardiorespiratory benefits in ...
10.
today.uconn.edu
today.uconn.edu/2025/08/air-purifiers-may-reduce-heart-risks-for-people-exposed-to-traffic-pollution/Air Purifiers May Reduce Heart Risks for People Exposed to ...
UConn School of Medicine study finds in-home HEPA air filters significantly lowered systolic blood pressure in adults with elevated readings.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.